文献速递乳房整形与再造

传统与机器人辅助即刻乳房再造:再造结局与患者报告结局比较

Conventional versus Robot-Assisted Immediate Breast Reconstruction: Reconstructive Outcome and Patient-Reported Outcome Measures.
PubMed 文献 · Plast Reconstr Surg · 2024-09-20

该回顾性研究比较2019年7月至2021年10月间传统与机器人辅助乳房切除及乳房再造,纳入传统组423例患者473侧乳房、机器人组153例患者164侧乳房,评估人口学与肿瘤学数据、再造结局及BREAST-Q患者报告结局,并分别分析植入物与自体组织再造。结果显示植入物再造中传统组需手术清创的皮肤坏死发生率8.0%显著高于机器人组2.0%(P=0.035);术后6至12个月机器人辅助再造在植入物再造的性健康评分和自体再造的躯体健康评分均高于传统再造。作者认为机器人手术可能是乳房切除与乳房再造的良好选择。

要点

  • 植入物再造中需手术清创的皮肤坏死发生率传统组8.0% vs 机器人组2.0%(P=0.035)。
  • 术后6至12个月BREAST-Q性健康评分机器人植入物再造高于传统再造。
  • 术后6至12个月BREAST-Q躯体健康评分机器人自体再造高于传统再造。

核心结论

  • 机器人辅助乳房切除与乳房再造相比传统方式与更少的皮肤坏死及更好的患者报告结局相关,涉及植入物再造的性健康和自体再造的躯体健康。
  • 作者认为机器人手术可能是乳房切除与乳房再造的良好选择。

研究设计与样本

  • 回顾性研究,纳入2019年7月至2021年10月间传统组423例患者473侧乳房和机器人组153例患者164侧乳房。
  • 评估人口学与肿瘤学数据、再造结局及BREAST-Q患者报告结局,植入物再造与自体再造分别分析。
  • 证据等级为治疗性III级。

主要发现

  • 植入物再造中需手术清创的皮肤坏死发生率传统组8.0% vs 机器人组2.0%(P=0.035)。
  • 术后6至12个月BREAST-Q性健康评分机器人植入物再造高于传统植入物再造。
  • 术后6至12个月BREAST-Q躯体健康评分机器人自体再造高于传统自体再造。

临床怎么用

  • 作者认为机器人手术可能是乳房切除与乳房再造的良好选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In this study, the authors compared conventional and robot-assisted mastectomy and breast reconstruction. To the authors' knowledge, this study is the first to report the results of robot-assisted mastectomy and breast reconstruction and provide a comparison of patient-reported outcomes. METHOD: This retrospective study included 473 breasts of 423 patients who underwent conventional mastectomy and breast reconstruction and 164 breasts of 153 patients who underwent robot-assisted mastectomy and breast reconstruction from July of 2019 to October of 2021. Demographic and oncologic data, reconstructive outcomes, and patient-reported outcomes (BREAST-Q) were evaluated. The results of implant-based and autologous breast reconstruction were evaluated separately. RESULTS: Skin necrosis requiring surgical débridement occurred significantly more frequently in the conventional group (8.0%) than in the robot-assisted group (2.0%) in implant-based reconstruction ( P = 0.035). At 6 to 12 months, patients who underwent robot-assisted breast reconstruction showed a higher Sexual Well-being score for implant-based reconstruction and a higher Physical Well-being score for autologous breast reconstruction than conventional breast reconstruction according to the BREAST-Q questionnaire. CONCLUSIONS: Robot-assisted mastectomy and breast reconstruction was associated with less skin necrosis and better patient-reported outcomes (Sexual Well-being for implant-based reconstruction and Physical Well-being for autologous breast reconstruction) than the conventional option. Robotic surgery could be a good option for mastectomy and breast reconstruction. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Kim HB, Min JC, Lee SB, et al. Conventional versus Robot-Assisted Immediate Breast Reconstruction: Reconstructive Outcome and Patient-Reported Outcome Measures. Plast Reconstr Surg. 2024. PMID: 37983857. doi:10.1097/PRS.0000000000011205

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。